7
Views
53
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Opposing Roles of the Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Cascades in Ras-Mediated Downregulation of Tropomyosin

, , &
Pages 2304-2317 | Received 02 Nov 2001, Accepted 20 Dec 2001, Published online: 28 Mar 2023

REFERENCES

  • Abe, K., I. P. Whitehead, J. P. O'Bryan, and C. J. Der. 1999. Involvement of N-terminal sequences in the negative regulation of Vav signaling and transforming activity. J. Biol. Chem. 274: 30410–30418.
  • Alaiya, A. A., B. Franzen, K. Fujioka, B. Moberger, K. Schedvins, C. Silfversvard, S. Linder, and G. Auer. 1997. Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors. Int. J. Cancer 73: 678–683.
  • Bigey, P., S. Ramchandani, J. Theberge, F. D. Araujo, and M. Szyf. 2000. Transcriptional regulation of the human DNA Methyltransferase (dnmt1) gene. Gene 242: 407–418.
  • Bishop, A. L., and A. Hall. 2000. Rho GTPases and their effector proteins. Biochem. J. 348(Pt. 2): 241–255.
  • Braverman, R. H., H. L. Cooper, H. S. Lee, and G. L. Prasad. 1996. Anti-oncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences. Oncogene 13: 537–545.
  • Button, E., C. Shapland, and D. Lawson. 1995. Actin, its associated proteins, and metastasis. Cell Motil. Cytoskeleton 30: 247–251.
  • Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294–5299.
  • Coller, H. A., C. Grandori, P. Tamayo, T. Colbert, E. S. Lander, R. N. Eisenman, and T. R. Golub. 2000. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl. Acad. Sci. USA 97: 3260–3265.
  • Contente, S., K. Kenyon, P. Sriraman, S. Subramanyan, and R. M. Friedman. 1999. Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene. Mol. Cell. Biochem. 194: 79–91.
  • Cooper, H. L., B. Bhattacharya, R. H. Bassin, and D. S. Salomon. 1987. Suppression of synthesis and utilization of tropomyosin in mouse and rat fibroblasts by transforming growth factor alpha: a pathway in oncogene action. Cancer Res. 47: 4493–4500.
  • Coso, O. A., M. Chiariello, J.-C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki, and J. S. Gutkind. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81: 1137–1146.
  • Deng, C., J. Yang, J. Scott, S. Hanash, and B. C. Richardson. 1998. Role of the ras-MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation. Biol. Chem. 379: 1113–1120.
  • Gabbiani, G., J. Csank-Brassert, J. C. Schneeberger, Y. Kapanci, P. Trenchev, and E. J. Holborow. 1976. Contractile proteins in human cancer cells. Immunofluorescent and electron microscopic study. Am. J. Pathol. 83: 457–474.
  • Gangarosa, L. M., N. Sizemore, R. Graves-Deal, S. M. Oldham, C. J. Der, and R. J. Coffey. 1997. A Raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells. J. Biol. Chem. 272: 18926–18931.
  • Gimona, M., J. A. Kazzaz, and D. M. Helfman. 1996. Forced expression of tropomyosin 2 or 3 in v-Ki-ras-transformed fibroblasts results in distinct phenotypic effects. Proc. Natl. Acad. Sci. USA 93: 9618–9623.
  • Guan, R. J., Y. Fu, P. R. Holt, and A. B. Pardee. 1999. Association of K-ras mutations with p16 methylation in human colon cancer. Gastroenterology 116: 1063–1071.
  • Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science 279: 509–514.
  • Han, J., K. Luby-Phelps, B. Das, X. Shu, Y. Xia, R. D. Mosteller, U. M. Krishna, J. R. Falck, M. A. White, and D. Broek. 1998. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 279: 558–560.
  • Hashimoto, Y., N. Shindo-Okada, M. Tani, K. Takeuchi, H. Toma, and J. Yokota. 1996. Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display. Cancer Res. 56: 5266–5271.
  • Hemstreet, G. P., J. Rao, R. E. Hurst, R. B. Bonner, P. Waliszewski, H. B. Grossman, M. Liebert, and B. L. Bane. 1996. G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials. J. Cell Biochem. Suppl. 25: 197–204.
  • Hendricks, M., and H. Weintraub. 1981. Tropomyosin is decreased in transformed cells. Proc. Natl. Acad. Sci. USA 78: 5633–5637.
  • Hubank, M., and D. G. Schatz. 1994. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 22: 5640–5648.
  • Jancso, A., and P. Graceffa. 1991. Smooth muscle tropomyosin coiled-coil dimers. Subunit composition, assembly, and end-to-end interaction. J. Biol. Chem. 266: 5891–5897.
  • Janssen, R. A., and J. W. Mier. 1997. Tropomyosin-2 cDNA lacking the 3′ untranslated region riboregulator induces growth inhibition of v-Ki-ras-transformed fibroblasts. Mol. Biol. Cell 8: 897–908.
  • Janssen, R. A., K. G. Veenstra, P. Jonasch, E. Jonasch, and J. W. Mier. 1998. Ras- and Raf-induced downmodulation of non-muscle tropomyosin are MEK-independent. J. Biol. Chem. 273: 32182–32186.
  • Jo, H., R. Zhang, H. Zhang, T. A. McKinsey, J. Shao, R. D. Beauchamp, D. W. Ballard, and P. Liang. 2000. NF-κB is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis. Oncogene 19: 841–849.
  • Jones, P. A. 1985. Altering gene expression with 5-azacytidine. Cell 40: 485–486.
  • Khosravi-Far, R., M. Chrzanowska-Wodnicka, P. A. Solski, A. Eva, K. Burridge, and C. J. Der. 1994. Vav and Dbl mediate transformation via Ras-independent mitogen activated protein kinase activation. Mol. Cell. Biol. 14: 6848–6857.
  • Khosravi-Far, R., P. A. Solski, M. S. Kinch, K. Burridge, and C. J. Der. 1995. Activation of Rac and Rho, and mitogen activated protein kinases, are required for Ras transformation. Mol. Cell. Biol. 15: 6443–6453.
  • Lehrer, S. S., and W. F. Stafford. 1991. Preferential assembly of the tropomyosin heterodimer: equilibrium studies. Biochemistry 30: 5682–5688.
  • Lisitsyn, N., and M. Wigler. 1993. Cloning the differences between two complex genomes. Science 259: 946–951.
  • Ljungdahl, S., S. Linder, B. Franzen, B. Binetruy, G. Auer, and M. C. Shoshan. 1998. Downregulation of tropomyosin-2 expression in c-Jun-transformed rat fibroblasts involves induction of a MEK1-dependent autocrine loop. Cell Growth Differ. 9: 565–573.
  • MacLeod, A. R., J. Rouleau, and M. Szyf. 1995. Regulation of DNA methylation by the Ras signaling pathway. J. Biol. Chem. 270: 11327-11337.
  • Marshall, C. J. 1996. Ras effectors. Curr. Opin. Cell Biol. 8: 197–204.
  • Marte, B. M., and J. Downward. 1997. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci. 22: 355–358.
  • Masuda, A., K. Takenaga, F. Kondoh, H. Fukami, K. Utsumi, and H. Okayama. 1996. Role of a signal transduction pathway which controls disassembly of microfilament bundles and suppression of high-molecular-weight tropomyosin expression in oncogenic transformation of NRK cells. Oncogene 12: 2081–2088.
  • Matsumura, F., J. J. Lin, S. Yamashiro-Matsumura, G. P. Thomas, and W. C. Topp. 1983. Differential expression of tropomyosin forms in the microfilaments isolated from normal and transformed rat cultured cells. J. Biol. Chem. 258: 13954–13964.
  • McFall, A., A. Ulku, Q. T. Lambert, A. Kusa, K. Rogers-Graham, and C. J. Der. 2001. Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase. Mol. Cell. Biol. 16: 5488–5499.
  • Minden, A., A. Lin, F.-X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81: 1147–1157.
  • Nimnual, A. S., B. A. Yatsula, and D. Bar-Sagi. 1998. Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science 279: 560–563.
  • Oldham, S. M., G. J. Clark, L. M. Gangarosa, R. J. Coffey, Jr., and C. J. Der. 1996. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc. Natl. Acad. Sci. USA 93: 6924–6928.
  • Oldham, S. M., A. D. Cox, E. R. Reynolds, N. S. Sizemore, R. J. Coffey, Jr., and C. J. Der. 1998. Ras, but not Src, transformation of RIE-1 epithelial cells is dependent on activation of the mitogen-activated protein kinase cascade. Oncogene 16: 2565–2573.
  • Peli, J., M. Schroter, C. Rudaz, M. Hahne, C. Meyer, E. Reichmann, and J. Tschopp. 1999. Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J. 18: 1824–1831.
  • Pittenger, M. F., J. A. Kazzaz, and D. M. Helfman. 1994. Functional properties of non-muscle tropomyosin isoforms. Curr. Opin. Cell Biol. 6: 96–104.
  • Plattner, R., M. J. Anderson, K. Y. Sato, C. L. Fasching, C. J. Der, and E. J. Stanbridge. 1996. Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. Proc. Natl. Acad. Sci. USA 93: 6665–6670.
  • Prasad, G. L., R. A. Fuldner, R. Braverman, E. McDuffie, and H. L. Cooper. 1994. Expression, cytoskeletal utilization and dimer formation of tropomyosin derived from retroviral-mediated cDNA transfer. Metabolism of tropomyosin from transduced cDNA. Eur. J. Biochem. 224: 1–10.
  • Prasad, G. L., R. A. Fuldner, and H. L. Cooper. 1993. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc. Natl. Acad. Sci. USA 90: 7039–7043.
  • Prasad, G. L., L. Masuelli, M. H. Raj, and N. Harindranath. 1999. Suppression of src-induced transformed phenotype by expression of tropomyosin-1. Oncogene 18: 2027–2031.
  • Ramchandani, S., A. R. MacLeod, M. Pinard, E. von Hofe, and M. Szyf. 1997. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 94: 684–689.
  • Rodriguez-Viciana, P., P. H. Warne, R. Dhand, B. Vanhaesebroeck, I. Gout, M. J. Fry, M. D. Waterfield, and J. Downward. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370: 527–532.
  • Rodriguez-Viciana, P., P. H. Warne, A. Khwaja, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, and J. Downward. 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89: 457–467.
  • Rouleau, J., A. R. MacLeod, and M. Szyf. 1995. Regulation of the DNA methyltransferase by the Ras-AP-1 signaling pathway. J. Biol. Chem. 270: 1595–1601.
  • Rountree, M. R., K. E. Bachman, J. G. Herman, and S. B. Baylin. 2001. DNA methylation, chromatin inheritance, and cancer. Oncogene 20: 3156–3165.
  • Schulze, A., K. Lehmann, H. B. Jefferies, M. McMahon, and J. Downward. 2001. Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev. 15: 981–994.
  • Secker-Walker, L. M. 1998. General Report on the European Union Concerted Action Workshop on 11q23. Leukemia 12: 776–778.
  • Shah, V., R. Braverman, and G. L. Prasad. 1998. Suppression of neoplastic transformation and regulation of cytoskeleton by tropomyosins. Somat. Cell Mol. Genet. 24: 273–280.
  • Shields, J. M., S. Powers, and C. J. Der. 2001. Identification of Ras-regulated genes by representational difference analysis. Methods Enzymol. 332: 221–232.
  • Shields, J. M., K. Pruitt, A. McFall, A. Shaub, and C. J. Der. 2000. Understanding Ras: “it ain't over 'til it's over.” Trends Cell Biol. 10: 147–153.
  • Shields, J. M., K. Rogers-Graham, and C. J. Der. Loss of transgelin in breast and colon tumors and in RIE-1 cells by ras deregulation of gene expression through Raf-independent pathways. J. Biol. Chem., in press.
  • Shirasawa, S., M. Furuse, N. Yokoyama, and T. Sasazuki. 1993. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260: 85–88.
  • Szyf, M., J. Theberge, and V. Bozovic. 1995. Ras induces a general DNA demethylation activity in mouse embryonal P19 cells. J. Biol. Chem. 270: 12690–12696.
  • Takenaga, K., and A. Masuda. 1994. Restoration of microfilament bundle organization in v-raf-transformed NRK cells after transduction with tropomyosin 2 cDNA. Cancer Lett. 87: 47–53.
  • Takenaga, K., Y. Nakamura, and S. Sakiyama. 1988. Differential expression of a tropomyosin isoform in low- and high-metastatic Lewis lung carcinoma cells. Mol. Cell. Biol. 8: 3934–3937.
  • Takenaga, K., Y. Nakamura, and S. Sakiyama. 1988. Suppression of synthesis of tropomyosin isoform 2 in metastatic v-Ha-ras-transformed NIH3T3 cells. Biochem. Biophys. Res. Commun. 157: 1111–1116.
  • Thirman, M. J., H. J. Gill, R. C. Burnett, D. Mbangkollo, N. R. McCabe, H. Kobayashi, S. Ziemin-van der Poel, Y. Kaneko, R. Morgan, and A. A. Sandberg. 1993. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N. Engl. J. Med. 329: 909–914.
  • Vertino, P. M., R. W. Yen, J. Gao, and S. B. Baylin. 1996. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol. Cell. Biol. 16: 4555–4565.
  • Wang, F. L., Y. Wang, W. K. Wong, Y. Liu, F. J. Addivinola, P. Liang, L. B. Chen, P. W. Kantoff, and A. B. Pardee. 1996. Two differentially expressed genes in normal human prostate tissue and in carcinoma. Cancer Res. 56: 3634–3637.
  • Wirth, P. J., L. D. Luo, Y. Fujimoto, and H. C. Bisgaard. 1992. Two-dimensional electrophoretic analysis of transformation-sensitive polypeptides during chemically, spontaneously, and oncogene-induced transformation of rat liver epithelial cells. Electrophoresis 13: 305–320.
  • Xie, S., Z. Wang, M. Okano, M. Nogami, Y. Li, W. W. He, K. Okumura, and E. Li. 1999. Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene 236: 87–95.
  • Yoder, J. A., R. W. C. Yen, P. M. Vertino, T. H. Bestor, and S. B. Baylin. 1996. New 5′ regions of the murine and human genes for DNA (cytosine-5)-methyltransferase. J. Biol. Chem. 271: 31092–31097.
  • Zohn, I. M., S. L. Campbell, R. Khosravi-Far, K. L. Rossman, and C. J. Der. 1998. Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene 17: 1415–1438.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.